Intervention Review

Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease

  1. Robert Caslake2,
  2. Angus Macleod3,
  3. Natalie Ives4,
  4. Rebecca Stowe4,
  5. Carl Counsell1,*

Editorial Group: Cochrane Movement Disorders Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 19 FEB 2009

DOI: 10.1002/14651858.CD006661.pub2

How to Cite

Caslake R, Macleod A, Ives N, Stowe R, Counsell C. Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD006661. DOI: 10.1002/14651858.CD006661.pub2.

Author Information

  1. 1

    University of Aberdeen, Division of Applied Health Sciences, Aberdeen, UK

  2. 2

    University of Aberdeen, Medecine & Therapeutics, Aberdeen, UK

  3. 3

    University of Aberdeen, Medicine and Therapeutics, Aberdeen, UK

  4. 4

    Robert Aitken Institute, University of Birmingham, Birmingham Clinical Trials Unit, School of Cancer Sciences, Birmingham, UK

*Carl Counsell, Division of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK. carl.counsell@abdn.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 7 OCT 2009

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >